ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
BioPharmX Corporation
0.5100
0.0000
成交量:
- -
成交額:
- -
市值:
932.19萬
市盈率:
-0.68
高:
0.5100
開:
0.5100
低:
0.5100
收:
0.5100
52周最高:
1.18
52周最低:
0.2500
股本:
1,827.82萬
流通股本:
1,607.39萬
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-0.7497
每股收益(LYR):
-0.7497
淨資產收益率:
-2020.23%
總資產收益率:
-209.33%
市淨率:
13.00
市盈率(LYR):
-0.68
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字:
BioPharmX Corporation
交易所:
AMEX
成立時間:
- -
員工人數:
- -
公司地址:
- -
官網:
http://www.BioPharmX.com
郵編:
- -
電話:
- -
傳真:
- -
簡介:
Biopharmx Corporation是根據特拉華州法律註冊成立,最初成立於2010年8月30日在內華達州以湯普森設計公司的名字,公司只有一個全資子公司——BioPharmX公司,在內華達州註冊的公司。公司是一家專業製藥公司,專註於利用其專利藥物輸送技術開發和商業化的新處方藥和非處方或OTC,即解決婦女的健康和皮膚的大市場的產品。該公司的目標是開發出治療健康或年齡有關的條件:(1)不被目前在所有或(2)處理或處理當前與藥物治療或藥物遞送方法是最理想的治療產品。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BPMX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BPMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BPMX\",,,,,undefined,":{"symbol":"BPMX","market":"US","secType":"STK","nameCN":"BioPharmX Corporation","latestPrice":0.51,"timestamp":1589832000000,"preClose":0.51,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":16073891,"shares":18278219,"eps":-0.749709,"marketStatus":"盤前交易","change":0,"latestTime":"03-18 08:24:13 EDT","open":0.51,"high":0.51,"low":0.51,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.749709,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1773840600000},"marketStatusCode":1,"symbolChange":{"newSymbol":"TMBR","executeDate":"2020-05-19"},"adr":0,"adrRate":0,"listingDate":1435204800000,"exchange":"AMEX","adjPreClose":0.51,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BPMX\",,,,,undefined,":{"symbol":"BPMX","floatShares":16073891,"roa":"-209.33%","roe":"-2020.23%","lyrEps":-0.749709,"shares":18278219,"dividePrice":0,"high":0.51,"amplitude":0,"preClose":0.51,"low":0.51,"week52Low":0.25,"pbRate":"13.00","week52High":1.18,"institutionHeld":0,"latestPrice":0.51,"eps":-0.749709,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.749709,"open":0.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BPMX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-19","symbol":"BPMX","type":"split","dateTimestamp":1589860800000,"forFactor":12,"toFactor":1,"ratio":12},{"market":"US","date":"2020-05-19","symbol":"BPMX","oldSymbol":"BPMX","newSymbol":"TMBR","exchange":"AMEX","type":"symbolChange","dateTimestamp":1589860800000},{"market":"US","date":"2020-04-30","symbol":"BPMX","fiscalQuarterEnding":"2020/01","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1588219200000,"reportTimeType":"","actualEps":-0.25},{"market":"US","date":"2019-12-10","symbol":"BPMX","fiscalQuarterEnding":"2019/10","expectedEps":-0.11,"name":null,"time":"","type":"earning","dateTimestamp":1575954000000,"reportTimeType":"","actualEps":-0.14},{"market":"US","date":"2019-09-09","symbol":"BPMX","fiscalQuarterEnding":"2019/07","expectedEps":-0.33,"name":null,"time":"","type":"earning","dateTimestamp":1568001600000,"reportTimeType":"","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BPMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BPMX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.BioPharmX.com","stockEarnings":[{"period":"1week","weight":-0.9167},{"period":"1month","weight":-0.9167},{"period":"3month","weight":-0.9167},{"period":"6month","weight":-0.9167},{"period":"1year","weight":-0.9167},{"period":"ytd","weight":-0.9167}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0161},{"period":"3month","weight":-0.0009},{"period":"6month","weight":0.0129},{"period":"1year","weight":0.1827},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Biopharmx Corporation是根據特拉華州法律註冊成立,最初成立於2010年8月30日在內華達州以湯普森設計公司的名字,公司只有一個全資子公司——BioPharmX公司,在內華達州註冊的公司。公司是一家專業製藥公司,專註於利用其專利藥物輸送技術開發和商業化的新處方藥和非處方或OTC,即解決婦女的健康和皮膚的大市場的產品。該公司的目標是開發出治療健康或年齡有關的條件:(1)不被目前在所有或(2)處理或處理當前與藥物治療或藥物遞送方法是最理想的治療產品。","exchange":"AMEX","name":"BioPharmX Corporation","nameEN":"BioPharmX"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BPMX\",market:\"US\",,,undefined,":null}}